NCT00310648View on ClinicalTrials.gov

Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)

PHASE3CompletedINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

January 31, 2006

Conditions

Influenza

Interventions

BIOLOGICAL

Influenza vaccine

Trial Locations (1)

530021

Nanning, Guangxi

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Vaccines

All Listed Sponsors

collaborator

Novartis Vaccines

INDUSTRY

collaborator

Chiron s.r.l. Beijing Representative Office

UNKNOWN

lead

Novartis

INDUSTRY